SGAM
CORT icon

Smith Group Asset Management’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$662K Hold
9,019
0.04% 114
2025
Q1
$1.03M Sell
9,019
-6,389
-41% -$730K 0.08% 84
2024
Q4
$776K Buy
15,408
+152
+1% +$7.66K 0.06% 101
2024
Q3
$706K Buy
15,256
+3,081
+25% +$143K 0.06% 80
2024
Q2
$396K Buy
12,175
+73
+0.6% +$2.37K 0.04% 100
2024
Q1
$305K Hold
12,102
0.02% 170
2023
Q4
$393K Buy
+12,102
New +$393K 0.02% 142
2021
Q4
Sell
-27,422
Closed -$540K 373
2021
Q3
$540K Sell
27,422
-1,458
-5% -$28.7K 0.03% 128
2021
Q2
$635K Sell
28,880
-265
-0.9% -$5.83K 0.03% 118
2021
Q1
$693K Sell
29,145
-31,660
-52% -$753K 0.04% 97
2020
Q4
$1.59M Sell
60,805
-9,270
-13% -$243K 0.09% 90
2020
Q3
$1.22M Sell
70,075
-6,450
-8% -$112K 0.06% 95
2020
Q2
$1.29M Buy
76,525
+2,169
+3% +$36.5K 0.07% 93
2020
Q1
$884K Buy
74,356
+36,920
+99% +$439K 0.05% 96
2019
Q4
$453K Buy
+37,436
New +$453K 0.02% 154
2018
Q4
Sell
-37,505
Closed -$526K 454
2018
Q3
$526K Sell
37,505
-59,360
-61% -$833K 0.02% 198
2018
Q2
$1.52M Sell
96,865
-57,280
-37% -$901K 0.04% 145
2018
Q1
$2.54M Sell
154,145
-100,491
-39% -$1.65M 0.08% 108
2017
Q4
$4.6M Sell
254,636
-11,449
-4% -$207K 0.14% 101
2017
Q3
$5.14M Buy
266,085
+1,990
+0.8% +$38.4K 0.17% 92
2017
Q2
$3.12M Buy
264,095
+177,955
+207% +$2.1M 0.1% 132
2017
Q1
$944K Sell
86,140
-30
-0% -$329 0.03% 173
2016
Q4
$626K Buy
+86,170
New +$626K 0.02% 176
2016
Q3
Sell
-30,080
Closed -$164K 462
2016
Q2
$164K Buy
30,080
+12,300
+69% +$67.1K ﹤0.01% 280
2016
Q1
$83K Buy
17,780
+4,210
+31% +$19.7K ﹤0.01% 281
2015
Q4
$68K Buy
+13,570
New +$68K ﹤0.01% 312